dawahpharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.dawahpharma.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title Home | Dawah Pharma
Description ABOUT top of page Home Our Approach Our Team Current Market Pipeline Investor Documents Contact News injectable and ophthalmic pharmaceutical company We market
Keywords N/A
Server Information
WebSite dawahpharma favicondawahpharma.com
Host IP 185.230.63.107
Location -
Related Websites
Site Rank
More to Explore
dawahpharma.com Valuation
US$2,875,483
Last updated: 2023-05-02 12:32:02

dawahpharma.com has Semrush global rank of 3,680,879. dawahpharma.com has an estimated worth of US$ 2,875,483, based on its estimated Ads revenue. dawahpharma.com receives approximately 331,787 unique visitors each day. Its web server is located in -, with IP address 185.230.63.107. According to SiteAdvisor, dawahpharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,875,483
Daily Ads Revenue US$2,655
Monthly Ads Revenue US$79,629
Yearly Ads Revenue US$955,545
Daily Unique Visitors 22,120
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
dawahpharma.com. A 3600 IP: 185.230.63.107
dawahpharma.com. A 3600 IP: 185.230.63.186
dawahpharma.com. A 3600 IP: 185.230.63.171
dawahpharma.com. NS 86400 NS Record: ns0.wixdns.net.
dawahpharma.com. NS 86400 NS Record: ns1.wixdns.net.
dawahpharma.com. MX 3600 MX Record: 10 aspmx.l.google.com.
dawahpharma.com. MX 3600 MX Record: 20 alt1.aspmx.l.google.com.
dawahpharma.com. MX 3600 MX Record: 50 alt4.aspmx.l.google.com.
dawahpharma.com. MX 3600 MX Record: 30 alt2.aspmx.l.google.com.
dawahpharma.com. MX 3600 MX Record: 40 alt3.aspmx.l.google.com.
HtmlToTextCheckTime:2023-05-02 12:32:02
top of page Home Our Approach Our Team Current Market Pipeline Investor Documents Contact News injectable and ophthalmic pharmaceutical company We market and manufacture a growing portfolio of FDA-approved medicines, including several generic alternatives, in the United States. Our products include both injectable and ophthalmic prescription medicines. Dawah Pharmaceuticals will produce sterile injectable medications that are currently in demand in the marketplace. We are currently submitting our first product to the FDA, expected to reach the market in early 2023. Filling the Gap Construction of our manufacturing facility is assumed to begin in 2024 and will take through 2026 to complete. Future State of the Art Aseptic Production Facility The first 8 products will initially be produced through independent third-party manufacturers (CMO’s) until we can complete the construction of our own production facility. Those products will initially come to market from 2023 through 2024. Our
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sun, 24 Oct 2021 22:23:05 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.dawahpharma.com/
strict-transport-security: max-age=120
Age: 14442
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: 6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVi+P0yj8Af8/paqX0JLrR68,m0j2EEknGIVUW/liY8BLLoDDUCbOI58b1sA1oICy9dYa0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalsZjVgKpxsuUO4/lSEpVXwXaIhvecWWGftwCc00z2HIHJ5C/ib4EvZ+4PO2vE/03kw==,2UNV7KOq4oGjA5+PKsX47BkjjUWaXQKmL2j7lKW7y1wfbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1635114185.7223223035185126946
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sun, 24 Oct 2021 22:23:05 GMT
content-type: text/html; charset=UTF-8
content-length: 479107
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"a204ca6dc09225e6dd6a3c929b323a8c"
content-language: en
strict-transport-security: max-age=120
age: 24163
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Sun, 24 Oct 2021 15:40:42 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YWiQHDYdb/mh+x60VrcL3mI=,6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVi9UwUuevlgidOw7LozzCz1,m0j2EEknGIVUW/liY8BLLvn/1fMuxpYw/Htpcq27vLUa0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalsDmyhxJC0PlUxqx2RhYuSxNywFbaK0V3JxRJiKQNli2cwl/k3RNCJuSwgaosCahQw==,2UNV7KOq4oGjA5+PKsX47BkjjUWaXQKmL2j7lKW7y1wfbJaKSXYQ/lskq2jK6SGP
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635114185.8853213809332516048
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e9313132ded77223b84617e3698f7c3a015a738509ff0a85b1022138a78049e0ee44887d05d8e3e5f48599956606889697294d; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10
dawahpharma.com Whois Information
Domain Name: DAWAHPHARMA.COM
Registry Domain ID: 2187616912_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.google.com
Registrar URL: http://domains.google.com
Updated Date: 2020-11-15T22:55:09Z
Creation Date: 2017-11-15T19:26:12Z
Registry Expiry Date: 2021-11-15T19:26:12Z
Registrar: Google LLC
Registrar IANA ID: 895
Registrar Abuse Contact Email: registrar-abuse@google.com
Registrar Abuse Contact Phone: +1.8772376466
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS0.WIXDNS.NET
Name Server: NS1.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-13T04:08:21Z <<<